Flecainide alters the cardiac microscopic activation pattern. An in-vitro study using voltage sensitive dyes

Pharmacological Research

Volumn 34, Issue 3-4, 1996, Pages 125-130

  Dhein, Stefan ^a,c   Hartbauer, M ^b   Muller W ^b   Windisch, H ^b   Salameh, A ^a   Tritthart, H A ^b  

^a Institut fur Pharmakologie   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antiarrhythmic drug action; Arrhythmia; Flecainide; Optical mapping; Proarrhythmic drug effects; Voltage sensitive dyes

Indexed keywords

DYE; FLECAINIDE;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARGON LASER; ARTICLE; CALCULATION; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIODE; FLUORESCENCE; GUINEA PIG; HEART ARRHYTHMIA; HEART PAPILLARY MUSCLE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030239446     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0076     Document Type: Article

References (39)

1. 1. CAST-investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl J Med 1990; 321: 393-8.
2. 2. Echt DS et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The cardiac arrhythmia suppression trial. New Engl J Med 1991; 324: 781-8.
3. 3. Brugada P, Wellens HJJ. Arrhythmogenesis of antiarrhythmic drugs. Am J Cardiol 1988; 61: 1108-11.
4. 4. Podrid PJ. Aggravation of ventricular arrhythmia. A drug induced complication. Drugs 1985; 29(4): 33-44.
5. 5. Podrid PJ, Lampert S, Rayboys TB, Blatt CM, Lown B. Aggravation of arrhythmia by antiarrhythmic drugs - Incidence and predictors. Am J Cardiol 1987; 59: 38-44.
6. 6. Dhein S, Müller A, Klaus W. The proarrhythmic risk of flecainide, propafenone and lidocaine in isolated rabbit hearts. Med Sci Res 1990; 18: 111-3.
7. 7. Dhein S, Müller A, Gerwin R, Klaus W. Comparative study on the proarrhythmic effects of some class I antiarrhythmic agents. Circulation 1993; 87: 617-31.
8. 8. Litovsky SH, Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res 1988; 62: 116-26.
9. 9. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M-cell. Circ Res 1991; 68: 1729-47.
10. 10. Watanabe T, Rautaharju PM, McDonald TF. Ventricular action potentials, ventricular extracellular potentials and the ECG of the guinea pig. Circ Res 1985; 57: 363-73.
11. 11. Müller W, Windisch H, Tritthart HA. Fast optical monitoring of microscopic excitation patterns. Biophys J 1989; 56: 623-9.
12. 12. Durrer D, Van der Tweel LH. Spread of activation in the left ventricular wall of the dog. II. Activation conditions at the epicardial surface. Am Heart J 1954; 47: 192-203.
13. 13. Müller W, Windisch H, Tritthart HA. Fluorescent styryl dyes applied as fast optical probes of cardiac action potential. Eur Biophys J 1986; 14: 103-11.
14. 14. Windisch H, Müller W, Tritthart HA. Fluorescence monitoring of rapid changes in membrane potential in heart muscle. Biophys J 1985; 48: 877-84.
15. 15. Dhein S, Rutten P, Klaus W. A new method for analysing the geometry and timecourse of epicardial potential spreading. Int J Biomed Comput 1988; 23: 201-7.
16. 16. Dhein S, Müller A, Klaus W. The potential of epicardial activation mapping for the assessment of arrhythmogenic and antiarrhythmic drug activity. J Pharmacol Meth 1989; 22: 197-206.
17. 17. Dhein S, Müller A, Klaus W. Prearrhythmia: changes preceeding arrhythmia, new aspects by epicardial mapping. Basic Res Cardiol 1990; 85: 285-96.
18. 18. Müller A, Dhein S, Klaus W. Heterogeneously distributed sensitivities to potassium as a cause of hypokalemic arrhythmias in isolated rabbit hearts. J Cardiovasc Electrophysiol 1991; 2: 145-55.
19. 19. Nusser E, Trieb G. Herzrhythmusstörungen. Stuttgart: Schattauer Verlag, 1990: 1-300.
20. 20. Fluhler E, Burnham VG, Loew LM. Spectra, membrane binding and potentiometric responses of new charge shift probes. Biochemistry 1985; 24: 5749-55.
21. 21. Loew LM, Cohen LB, Dix J, Fluhler EN, Montana V, Salama G, Jian-young W. A naphthyl analog of the aminostyryl pyridinium class of potentiometric membrane dyes shows consistent sensitivity in a variety of tissue, cell, and model membrane preparations. J Membrane Biol 1992; 130: 1-10.
22. 22. Draper MH, Mya Tu M. A comparison of the conduction velocity in cardiac tissues of various mammals. J Exp Physiol 1959; 64: 92-109.
23. 23. Spach MS, Dolber PC. Discontinuous anisotropic propagation. In: Rosen MR, Janse MJ, Wit AL (Eds). Cardiac electrophysiology. New York: Futura Publishing Company Inc., 1990: 517-34.
24. 24. Lesh MD, Pring M, Spear JF. Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardium. A computer modeling study. Circ Res 1989; 65: 1426-40.
25. 25. Müller A, Dhein S. Sodium channel blockade enhances dispersion of the cardiac action potential duration. A computer simulation study. Basic Res Cardiol 1993; 88: 11-22.
26. 26. Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle. A model of reentry based on anisotropic discontinuous propagation. Circ Res 1988; 62: 811-32.
27. 27. Spach MS, Dolber PC, Heidlage JF. Interaction of inhomogeneties of repolarization with anisotropic propagation in dog atria. A mechanism for both preventing and initiating reentry. Circ Res 1989; 65: 1612-31.
28. 28. Arnsdorff MF, Schmidt GA, Sawicki GJ. Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers. J Pharmacol Exp Ther 1985; 232: 40-8.
29. 29. Arnsdorff MF, Sawicki GJ. Effects of quinidine sulfate on the balance among active and passive cellular properties that comprise the electrophysiologic matrix and determine excitability in sheep Purkinje fibers. Circ Res 1987; 61: 244-55.
30. 30. Arnsdorff MF. Electrophysiological matrices, cardiac arrhythmias and antiarrhythmic drugs. In: Rosen MR, Janse MJ, Wit AL (eds). Cardiac electrophysiology. New York: Futura Publishing Company Inc., 1990: 1063-94.
31. 31. Buchanan JW, Saito T, Kagiyama Y, Hill JL, Gettes S. The relationship between upstroke velocity and conduction in guinea pig myocardium. Am J Cardiol 1982; 49: 983.
32. 32. Buchanan JW, Saito T, Gettes S. The effects of antiarrhythmic drugs, stimulation frequency and potassium induced resting membrane potential changes on conduction velocity and dV/dt max in guinea pig myocardium. Circ Res 1985; 56: 696-703.
33. 33. Antoni H, Weirich J. Ventricular arrhythmias: medical, surgical and electrical treatment. Herz 1990; 15: 61-9.
34. 34. Hondeghem LM, Katzung BG. Time- and voltage dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 1984; 472: 373-98.
35. 35. Scholz H. Antiarrhythmische und kardiodepressive Wirkungen antiarrhythmischer Substanzen. Z Kardiol 1988; 77 (Suppl.): 113-9.
36. 36. Honerjäger P. The contribution of Na channel block to the negative inotropic effect of antiarrhythmic drugs. Basic Res Cardiol 1986; 81 (Suppl.): 33-7.
37. 37. Page E. Cardiac gap junctions. In: Fozzard HA (Ed.). The heart and cardiovascular system, 2nd ed., New York: Raven Press, 1992: 1003-47.
38. 38. Cole WC, Picone B, Sperelakis N. Gap junction uncoupling and discontinuous propagation in the heart. Biophys J 1988; 53: 809-18.
39. 39. Spach MS, Josephson ME. Initiating reentry: the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol 1994; 5: 182-209.